128 related articles for article (PubMed ID: 35166761)
1. Enhanced transglycosylation activity of an Endo-F3 mutant by ligand-directed localization.
Zou X; Liu Z; Liu L; Shi W; Li W; Guo Z; Tang F; Huang W
Org Biomol Chem; 2022 Apr; 20(15):3086-3095. PubMed ID: 35166761
[TBL] [Abstract][Full Text] [Related]
2. Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions.
Huang W; Giddens J; Fan SQ; Toonstra C; Wang LX
J Am Chem Soc; 2012 Jul; 134(29):12308-18. PubMed ID: 22747414
[TBL] [Abstract][Full Text] [Related]
3. Glycosynthase Mutants of Endoglycosidase S2 Show Potent Transglycosylation Activity and Remarkably Relaxed Substrate Specificity for Antibody Glycosylation Remodeling.
Li T; Tong X; Yang Q; Giddens JP; Wang LX
J Biol Chem; 2016 Aug; 291(32):16508-18. PubMed ID: 27288408
[TBL] [Abstract][Full Text] [Related]
4. Generation of a Mutant Mucor hiemalis Endoglycosidase That Acts on Core-fucosylated N-Glycans.
Katoh T; Katayama T; Tomabechi Y; Nishikawa Y; Kumada J; Matsuzaki Y; Yamamoto K
J Biol Chem; 2016 Oct; 291(44):23305-23317. PubMed ID: 27629418
[TBL] [Abstract][Full Text] [Related]
5. One-pot enzymatic glycan remodeling of a therapeutic monoclonal antibody by endoglycosidase S (Endo-S) from Streptococcus pyogenes.
Tong X; Li T; Orwenyo J; Toonstra C; Wang LX
Bioorg Med Chem; 2018 Apr; 26(7):1347-1355. PubMed ID: 28789910
[TBL] [Abstract][Full Text] [Related]
6. Generation and Comparative Kinetic Analysis of New Glycosynthase Mutants from Streptococcus pyogenes Endoglycosidases for Antibody Glycoengineering.
Tong X; Li T; Li C; Wang LX
Biochemistry; 2018 Sep; 57(35):5239-5246. PubMed ID: 30102520
[TBL] [Abstract][Full Text] [Related]
7. Endo-F3 Glycosynthase Mutants Enable Chemoenzymatic Synthesis of Core-fucosylated Triantennary Complex Type Glycopeptides and Glycoproteins.
Giddens JP; Lomino JV; Amin MN; Wang LX
J Biol Chem; 2016 Apr; 291(17):9356-70. PubMed ID: 26966183
[TBL] [Abstract][Full Text] [Related]
8. Site-selective chemoenzymatic glycoengineering of Fab and Fc glycans of a therapeutic antibody.
Giddens JP; Lomino JV; DiLillo DJ; Ravetch JV; Wang LX
Proc Natl Acad Sci U S A; 2018 Nov; 115(47):12023-12027. PubMed ID: 30397147
[TBL] [Abstract][Full Text] [Related]
9. Generation of efficient mutants of endoglycosidase from Streptococcus pyogenes and their application in a novel one-pot transglycosylation reaction for antibody modification.
Iwamoto M; Sekiguchi Y; Nakamura K; Kawaguchi Y; Honda T; Hasegawa J
PLoS One; 2018; 13(2):e0193534. PubMed ID: 29474426
[TBL] [Abstract][Full Text] [Related]
10. Site-specific immobilization of endoglycosidases for streamlined chemoenzymatic glycan remodeling of antibodies.
Li T; Li C; Quan DN; Bentley WE; Wang LX
Carbohydr Res; 2018 Mar; 458-459():77-84. PubMed ID: 29475193
[TBL] [Abstract][Full Text] [Related]
11. Glycan Remodeling of Human Erythropoietin (EPO) Through Combined Mammalian Cell Engineering and Chemoenzymatic Transglycosylation.
Yang Q; An Y; Zhu S; Zhang R; Loke CM; Cipollo JF; Wang LX
ACS Chem Biol; 2017 Jun; 12(6):1665-1673. PubMed ID: 28452462
[TBL] [Abstract][Full Text] [Related]
12. Glycosynthases enable a highly efficient chemoenzymatic synthesis of N-glycoproteins carrying intact natural N-glycans.
Huang W; Li C; Li B; Umekawa M; Yamamoto K; Zhang X; Wang LX
J Am Chem Soc; 2009 Feb; 131(6):2214-23. PubMed ID: 19199609
[TBL] [Abstract][Full Text] [Related]
13. Remarkable transglycosylation activity of glycosynthase mutants of endo-D, an endo-β-N-acetylglucosaminidase from Streptococcus pneumoniae.
Fan SQ; Huang W; Wang LX
J Biol Chem; 2012 Mar; 287(14):11272-81. PubMed ID: 22318728
[TBL] [Abstract][Full Text] [Related]
14. The Amazing Transglycosylation Activity of Endo-β-N-acetylglucosaminidases.
Wang LX
Trends Glycosci Glycotechnol; 2011; 23(129):33-52. PubMed ID: 25309039
[TBL] [Abstract][Full Text] [Related]
15. Glycoengineering and glycosite-specific labeling of serum IgGs from various species.
Guo W; Tang F; Qin K; Zhou M; Le Z; Huang W
Carbohydr Res; 2017 Jun; 446-447():32-39. PubMed ID: 28494315
[TBL] [Abstract][Full Text] [Related]
16. Chemoenzymatic synthesis of glycoengineered IgG antibodies and glycosite-specific antibody-drug conjugates.
Tang F; Wang LX; Huang W
Nat Protoc; 2017 Aug; 12(8):1702-1721. PubMed ID: 28749929
[TBL] [Abstract][Full Text] [Related]
17. Chemoenzymatic Defucosylation of Therapeutic Antibodies for Enhanced Effector Functions Using Bacterial α-Fucosidases.
Li C; Li T; Wang LX
Methods Mol Biol; 2018; 1827():367-380. PubMed ID: 30196507
[TBL] [Abstract][Full Text] [Related]
18. Chemoenzymatic glycan-selective remodeling of a therapeutic lysosomal enzyme with high-affinity M6P-glycan ligands. Enzyme substrate specificity is the name of the game.
Zhang X; Liu H; Meena N; Li C; Zong G; Raben N; Puertollano R; Wang LX
Chem Sci; 2021 Sep; 12(37):12451-12462. PubMed ID: 34603676
[TBL] [Abstract][Full Text] [Related]
19. Glycoengineering of antibody (Herceptin) through yeast expression and in vitro enzymatic glycosylation.
Liu CP; Tsai TI; Cheng T; Shivatare VS; Wu CY; Wu CY; Wong CH
Proc Natl Acad Sci U S A; 2018 Jan; 115(4):720-725. PubMed ID: 29311294
[TBL] [Abstract][Full Text] [Related]
20. Sculpting therapeutic monoclonal antibody N-glycans using endoglycosidases.
Trastoy B; Du JJ; García-Alija M; Li C; Klontz EH; Wang LX; Sundberg EJ; Guerin ME
Curr Opin Struct Biol; 2022 Feb; 72():248-259. PubMed ID: 34998123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
